Ethacizine (2-carbethoxyamino-10 (3-diethylaminopropionyl) phenothiazine hydrochloride) has been administered in a daily dose of 150-200 mg for 8-10 weeks to 46 patients with diffuse psoriasis. The treatment has been effective in 84.8% of the patients. Late results, followed up over a year in 40 patients, are fine.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[ethacizine treatment
4
treatment psoriasis]
4
psoriasis] ethacizine
4
ethacizine 2-carbethoxyamino-10
4
2-carbethoxyamino-10 3-diethylaminopropionyl
4
3-diethylaminopropionyl phenothiazine
4
phenothiazine hydrochloride
4
hydrochloride administered
4
administered daily
4
daily dose
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!